mutineer
发表于 2025-3-23 10:02:28
http://reply.papertrans.cn/67/6663/666270/666270_11.png
Constitution
发表于 2025-3-23 17:15:40
A Tale of Two Worldsand “impure” diagnoses. Neither investigators nor clinicians know whether the same mechanisms apply to both groups or whether the treatment algorithms should be the same. Investigators and clinicians rarely ask: Is there a gold standard for the concept, correct diagnosis? How precise must it be? For
整顿
发表于 2025-3-23 21:50:03
The Role of Microparticles as Biomarkers in the Development of Therapy for Autoimmune Disease elevated in the blood of patients with many autoimmune diseases, with flow cytometric assays using antibodies to cell surface markers allowing identification of the cell of origin. In the context of autoimmunity, MPs are important as a source of alarmins or DAMPs (damage-associated molecular patter
缺陷
发表于 2025-3-23 23:32:59
Bispecific Antibodiesies of points to consider where bsAbs may require special attention when compared to classical biologics for development. Related to mode of action and target is the selection of the right molecular format. We provide an overview on bsAb formats and then go more specifically over those used in molec
Herd-Immunity
发表于 2025-3-24 03:08:34
Targeting CD13 with Asn-Gly-Arg (NGR) Peptide-Drug Conjugatessting that the asparagine residue of NGR can rapidly undergo deamidation, a spontaneous reaction that changes NGR to isoDGR (an integrin-binding motif), and the potential biological, pharmacological, and toxicological implications of this sequence transition in peptide-drug conjugates.
BARGE
发表于 2025-3-24 07:05:25
Stem Cell Therapy in the Treatment of Rheumatic Diseases and Application in the Treatment of Systemicy, as observed in animal models, can be successfully translated in clinical trials. Current understanding, limitations, and future directions for SCT with respect to rheumatic diseases are also discussed.
羊栏
发表于 2025-3-24 11:06:22
http://reply.papertrans.cn/67/6663/666270/666270_17.png
LUDE
发表于 2025-3-24 15:15:19
http://reply.papertrans.cn/67/6663/666270/666270_18.png
摸索
发表于 2025-3-24 20:46:34
http://reply.papertrans.cn/67/6663/666270/666270_19.png
值得尊敬
发表于 2025-3-25 03:10:15
http://reply.papertrans.cn/67/6663/666270/666270_20.png